Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 10.99
+0.29 (2.71%)
Jul 31, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 5.69 billion as of July 31, 2026.
Market Cap
5.69B
Enterprise Value
4.97B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.99
ChartMarket Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 5.69B, a decrease of -58.21%. That is a compound annual growth rate of -66.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 5.69B | -84.41% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CanSino Biologics | 9.64B |
| Shandong Xinhua Pharmaceutical Company | 9.06B |
| Sihuan Pharmaceutical Holdings Group | 8.39B |
| Luye Pharma Group | 8.07B |
| China Traditional Chinese Medicine Holdings Co. | 7.20B |
| SSY Group | 7.06B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 6.66B |
| CF PharmTech | 6.45B |